Invention Grant
- Patent Title: Amino pyrimidine derivatives
-
Application No.: US15974190Application Date: 2018-05-08
-
Publication No.: US10457647B2Publication Date: 2019-10-29
- Inventor: Daniela Angst , Francois Gessier , Anna Vulpetti
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Gregory Houghton
- Priority: EP13195081 20131129
- Main IPC: C07D405/12
- IPC: C07D405/12 ; C07D403/12 ; A61K31/505 ; A61K31/506 ; C07D239/47 ; C07D401/14 ; C07D401/10 ; C07D401/12 ; A61P29/00 ; A61P35/02

Abstract:
The present invention describes new amino pyrimidine derivatives and pharmaceutically acceptable salts thereof which appear to interact with Bruton's tyrosine kinase (Btk). Accordingly, the novel amino pyrimidines may be effective in the treatment of autoimmune disorders, inflammatory diseases, allergic diseases, airway diseases, such as asthma and chronic obstructive pulmonary disease (COPD), transplant rejection, cancers e.g. of hematopoietic origin or solid tumors.
Public/Granted literature
- US20180251432A1 Novel Amino Pyrimidine Derivatives Public/Granted day:2018-09-06
Information query